Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMPU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $79,393
Award facts
- Contract value 100% obligated
- $79,393.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $79,393.28 by the Defense Logistics Agency on December 19, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a specific issuance under the company's broader Indefinite Delivery Contract with the DLA. The award is funded by the Defense Logistics Agency and specifies Park Ridge, Illinois as the place of performance, with an ultimate completion date of December 22, 2025.
This delivery order is issued under DMS Pharmaceutical Group's prime vendor contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceutical products to Department of Defense military healthcare facilities worldwide. The underlying PPV-G GEN V contract, valued at $499,999,999 and awarded on November 13, 2025, authorizes DLA to issue delivery orders for branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. DMS Pharmaceutical Group's established track record supplying diverse pharmaceutical categories—including oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals—demonstrates its capability to fulfill the specialized medical supply requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEMPU?
SPE2DU26FEMPU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DU26FEMPU worth?
The government has obligated $79,393 on SPE2DU26FEMPU.
Is contract SPE2DU26FEMPU an order under another contract?
Yes. SPE2DU26FEMPU is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMPU competed?
The extent of competition for SPE2DU26FEMPU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award